Autopsy and Case Reports
http://autopsyandcasereports.org/article/doi/10.4322/acr.2018.025
Autopsy and Case Reports
Article / Clinical Case Report

Unknown primary large-cell neuroendocrine tumor

Sara Póvoa; Daniela Azevedo; Cristiana Marques; Helena Barroca; Andreia Costa

Abstract

Large-cell neuroendocrine tumors (NETs) are poorly differentiated malignancies of rare incidence and aggressive nature. NETs mostly arise in the lung followed by the gastrointestinal tract, although they are potentially ubiquitous throughout the body. Primary unknown NET has a worse prognosis and shorter survival comparing with other NETs, with limited available data in the literature concerning this subgroup. The authors report the case of large-cell NET with supraclavicular lymph node presentation. Total excisional biopsy revealed an enlarged adenopathy 18 × 15 × 10 mm, which was extensively infiltrated by a solid malignant neoplasm composed of large cells with granular chromatin, nuclear pseudo-inclusions, high mitotic index, and focal necrosis, with a Ki 67 index 25-30% and positive immunohistochemical study for the expression of cytokeratin 8/18, chromogranin, synaptophysin, and thyroid transcriptional factor-1 (TTF-1). There was no evidence of primary location apart from two infracentimetric lung lesions that could not be accessed for biopsy and were negative at both somatostatin receptor scintigraphy and positron emission tomography. The NET relapsed with three mediastinal masses, so the patient was started on chemotherapy with carboplatin and etoposide with initial total response. Early progression showed no response to further chemotherapy regimens (temozolomide, oral etoposide); therefore, the patient was treated with local radiotherapy. This patient has an atypical long survival (54 months) compared to the literature data. In fact, there are few long-term survivors of large-cell NET and they are all related to complete surgical resection.

Keywords

Carcinoma, Neuroendocrine, Neoplasms, Unknown Primary, Neuroendocrine Tumors

References

Yao JC , Hassan M , Phan A , et al . One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States . J Clin Oncol . 2008 ; 26 ( 18 ): 3063 - 72 . 10.1200/JCO.2007.15.4377 . 18565894

Klimstra DS , Modlin IR , Coppola D , Lloyd RV , Suster S . The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems . Pancreas . 2010 ; 39 ( 6 ): 707 - 12 . 10.1097/MPA.0b013e3181ec124e . 20664470

Travis WD , Brambilla E , Nicholson AG , et al . The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification . J Thorac Oncol . 2015 ; 10 ( 9 ): 1243 - 60 . 10.1097/JTO.0000000000000630 . 26291008

Soto DE , Eisbruch A . Limited-stage extrapulmonary small-cell carcinoma: outcomes after modern chemotherapy and radiotherapy . Cancer J . 2007 ; 13 ( 4 ): 243 - 6 . 10.1097/PPO.0b013e31813ffe7c . 17762759

Spigel DR , Hainsworth JD , Greco FA . Neuroendocrine carcinoma of unknown primary site . Semin Oncol . 2009 ; 36 ( 1 ): 52 - 9 . 10.1053/j.seminoncol.2008.10.003 . 19179188

Dasari A , Mehta K , Byers LA , Sorbye H , Yao JC . Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: a SEER database analysis of 162,983 cases . Cancer . 2018 ; 124 ( 4 ): 807 - 15 . 10.1002/cncr.31124 . 29211313

Bohnenberger H , Dinter H , König A , Ströbel P . Neuroendocrine tumors of the thymus and mediastinum . J Thorac Dis . 2017 ; 9 ( Suppl 15 ): S1448 - 57 . 10.21037/jtd.2017.02.02 . 29201448

Ki EY , Park JS , Lee KH , Bae SN , Hur SY . Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature . World J Surg Oncol . 2014 ; 12 ( 1 ): 314 . 10.1186/1477-7819-12-314 . 25314924

Sood A , Williamson SR , Leavitt DA . Neuroendocrine tumor of the ureter: a zebra among horses . J Endourol Case Rep. 2016 ; 2 ( 1 ): 204 - 8 . 10.1089/cren.2016.0103 . 27868098

Terada T . Pathologic diagnosis of large cell neuroendocrine carcinoma of the lung in an axillary lymph node: a case report with immunohistochemical and molecular genetic studies . Int J Clin Exp Pathol . 2013 ; 6 ( 6 ): 1177 - 9 . 23696939

Greco FA , Vaughn WK , Hainsworth JD . Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome . Ann Intern Med . 1986 ; 104 ( 4 ): 547 - 53 . 10.7326/0003-4819-104-4-547 . 3006571

Hainsworth JD , Johnson DH , Greco FA . Poorly differentiated neuroendocrine carcinoma of unknown primary site (a newly recognized clinicopathologic entity) . Ann Intern Med . 1988 ; 109 ( 5 ): 364 - 71 . 10.7326/0003-4819-109-5-364 . 2841895

Wang SC , Parekh JR , Zuraek MB , et al . Identification of unknown primary tumors in patients with neuroendocrine liver metastases . Arch Surg . 2010 ; 145 ( 3 ): 276 - 80 . 10.1001/archsurg.2010.10 . 20231629

Yuan C , Keating B , Farricielli LA , Zhang K . Large-cell neuroendocrine carcinoma (LCNEC) without pulmonary symptoms diagnosed in a cutaneous metastasis . Am J Case Rep . 2014 ; 15 : 97 - 102 . 10.12659/AJCR.890094 . 24624250

Schneider KM , Martinez AY , Guglielmi M . Large cell neuroendocrine carcinoma: topic review and a unique case of metastasis to the mandible . J Maxillofac Oral Surg . 2015 ; 14 ( Suppl 1 ): 120 - 6 . 10.1007/s12663-012-0362-x . 25861184

Boyar Cetinkaya R , Aagnes B , Myklebust , Thiis-Evensen E . Survival in neuroendocrine neoplasms: a report from a large Norwegian population-based study . Int J Cancer . 2018 ; 142 ( 6 ): 1139 - 47 . 10.1002/ijc.31137 . 29082524

Sorbye H , Welin S , Langer SW , et al . Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study . Ann Oncol . 2013 ; 24 ( 1 ): 152 - 60 . 10.1093/annonc/mds276 . 22967994

Koumarianou A , Chatzellis E , Boutzios G , Tsavaris N , Kaltsas G . Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas . Endokrynol Pol . 2013 ; 64 ( 1 ): 60 - 72 . 23450449

Moertel CG , Kvols LK , O’Connell MJ , Rubin J . Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms . Cancer . 1991 ; 68 ( 2 ): 227 - 32 . 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I . 1712661

Mitry E , Baudin E , Ducreux M , et al . Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin . Br J Cancer . 1999 ; 81 ( 8 ): 1351 - 5 . 10.1038/sj.bjc.6690325 . 10604732

Mitry E , Rougier P . The treatment of undifferentiated neuroendocrine tumors . Crit Rev Oncol Hematol . 2001 ; 37 ( 1 ): 47 - 51 . 10.1016/S1040-8428(00)00073-1 . 11164718

Pavel M , Baudin E , Couvelard A , et al . ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary . Neuroendocrinology . 2012 ; 95 ( 2 ): 157 - 76 . 10.1159/000335597 . 22262022

Oberg K , Akerström G , Rindi G , Jelic S . Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up . Ann Oncol . 2010 ; 21 ( Suppl 5 ): v223 - 7 . 10.1093/annonc/mdq192 . 20555086

Caplin ME , Pavel M , Ćwikła JB , et al . Lanreotide in metastatic enteropancreatic neuroendocrine tumors . N Engl J Med . 2014 ; 371 ( 3 ): 224 - 33 . 10.1056/NEJMoa1316158 . 25014687

Berbari B , Romano A , Bhatti R et al. A case report of a poorly differentiated neuroendocrine carcinoma diagnosed in the bone marrow . Gastroenterol Hepatol Open Access. 2015 ; 3 ( 2 ): 73 .

Koumarianou A , Kaltsas G , Kulke MH , et al . Temozolomide in advanced neuroendocrine neoplasms: pharmacological and clinical aspects . Neuroendocrinology . 2015 ; 101 ( 4 ): 274 - 88 . 10.1159/000430816 . 25924937

Jungraithmayr W , Kayser G , Passlick B , Eggeling S . Neuroendocrine differentiation and neuroendocrine morphology at two different patterns in large-cell bronchial carcinomas: outcome after complete resection . World J Surg Oncol . 2006 ; 4 ( 1 ): 61 . 10.1186/1477-7819-4-61 . 16953887

Kamiyoshihara M , Ibe T , Igai H , et al . Roentgenological occult large-cell neuroendocrine carcinoma: report of a long-term survivor . Respir Med Case Rep. 2013 ; 8 : 14 - 7 . 10.1016/j.rmcr.2012.12.00 . 26029607

Shimono C , Suwa K , Sato M , et al . Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment . Int J Clin Oncol . 2009 ; 14 ( 4 ): 351 - 5 . 10.1007/s10147-008-0843-6 . 19705247

 

 

 

5b1ac3e60e88252e260cfe00 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections